BC20965 Taspoglutide vs Insulin Glargine in Type 2 diabetes

• Research type

  Research Study

• Full title

  A multi-centre, randomised, open-label, active-controlled study to compare the efficacy, safety and tolerability of taspoglutide (RO5073031) versus insulin glargine in insulin-naive type 2 diabetic patients inadequately controlled with metformin and sulphonylurea combination therapy.

• IRAS ID

  7186

• Contact name

  John Wilding

• Contact email

  j.p.h.wilding@liverpool.ac.uk

• Sponsor organisation

  F Hoffmann-La Roche AG

• Eudract number

  2008-001855-23

• Clinicaltrials.gov Identifier

  01051011

• REC name

  West of Scotland REC 1

• REC reference

  08/S0703/134

• Date of REC Opinion

  6 Nov 2008

• REC opinion

  Further Information Favourable Opinion